{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:52:23Z","timestamp":1790679143802,"version":"4.1.0"},"reference-count":110,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001807","name":"FAPESP","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"CAPES","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.pnpbp.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T13:07:58Z","timestamp":1553087278000},"page":"182-188","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders"],"prefix":"10.1016","volume":"93","author":[{"given":"Mariana","family":"Pedrini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o Victor Silva","family":"Nani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael O.","family":"Cerqueira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo B.","family":"Mansur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljubica","family":"Tasic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirian A.F.","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger S.","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Brietzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pnpbp.2019.03.010_bb0005","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1021\/ac981422i","article-title":"Concentration measurement by proton NMR using the ERETIC method","volume":"71","author":"Akoka","year":"1999","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neulet.2017.12.005","article-title":"Personalized management of bipolar disorder","volume":"669","author":"Alda","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb9005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jad.2017.12.030","article-title":"The correct authors is Ali-Sisto.Global arginine bioavailability ratio is decreased in patients with major depressive disorder","volume":"229","author":"Ali-Sisto","year":"2018","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0015","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1472-6882-4-15","article-title":"High sensitivity 1H-NMR spectroscopy of homeopathic remedies made in water","volume":"4","author":"Anick","year":"2004","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0020","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/jms.4070","article-title":"Liquid chromatography\/mass spectrometry-based plasma metabolic profiling study of escitalopram in subjects with major depressive disorder","volume":"53","author":"Bandu","year":"2018","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0025","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1021\/acs.analchem.7b04148","article-title":"LipSpin: a new bioinformatics tool for quantitative 1H NMR lipid profiling","volume":"90","author":"Barrilero","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0030","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1038\/nprot.2007.376","article-title":"Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts","volume":"2","author":"Beckonert","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1006018","article-title":"speaq 2.0: a complete workflow for high-throughput 1D NMR spectra processing and quantification","volume":"14","author":"Beirnaert","year":"2018","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0040","doi-asserted-by":"crossref","first-page":"6648","DOI":"10.1021\/ac201195d","article-title":"Serum lipidomics profiling using LC\u2013MS and high-energy collisional dissociation fragmentation: focus on triglyceride detection and characterization","volume":"83","author":"Bird","year":"2011","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0045","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/bib\/bbl016","article-title":"Partial least squares: a versatile tool for the analysis of high-dimensional genomic data","volume":"8","author":"Boulesteix","year":"2006","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0050","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1017\/S1092852912000338","article-title":"Cytokines in bipolar disorder: recent findings, deleterious effects but promise for future therapeutics","volume":"16","author":"Brietzke","year":"2011","journal-title":"CNS Spectr."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0055","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jad.2012.02.016","article-title":"Towards a multifactorial approach for prediction of bipolar disorder in at risk populations","volume":"140","author":"Brietzke","year":"2012","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0060","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/cts.12324","article-title":"An untargeted metabolomics analysis of antipsychotic use in bipolar disorder","volume":"8","author":"Burghardt","year":"2015","journal-title":"Clin. Transl. Sci."},{"issue":"3","key":"10.1016\/j.pnpbp.2019.03.010_bb0065","first-page":"223","article-title":"Machine learning for precision psychiatry: opportunites and challenges","volume":"3","author":"Bzdok","year":"2018","journal-title":"Biol. Psychiatry Cogn. Neurosci. Neuroimaging"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0070","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.trac.2014.04.017","article-title":"Comprehensive analysis of lipids in biological systems by liquid chromatography-mass spectrometry","volume":"61","author":"Cajka","year":"2014","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0075","first-page":"498","article-title":"Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration","volume":"18","author":"Cambiaghi","year":"2017","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0080","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3389\/fneur.2014.00019","article-title":"Experimental models of brain ischemia: a review of techniques, magnetic resonance imaging, and investigational cell-based therapies","volume":"5","author":"Canazza","year":"2014","journal-title":"Front. Neurol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0085","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1038\/srep05855","article-title":"Combined application of NMR-and GC-MS-based metabonomics yields a superior urinary biomarker panel for bipolar disorder","volume":"4","author":"Chen","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0090","doi-asserted-by":"crossref","first-page":"3382","DOI":"10.1021\/acs.jproteome.5b00434","article-title":"Divergent urinary metabolic phenotypes between major depressive disorder and bipolar disorder identified by a combined GC-MS and NMR spectroscopic metabonomic approach","volume":"14","author":"Chen","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0095","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2017.06.012","article-title":"Differential urinary metabolites related with the severity of major depressive disorder","volume":"332","author":"Chen","year":"2017","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0100","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.18632\/aging.101805","article-title":"Urinary metabolite signature in bipolar disorder patients during depressive episode","volume":"11","author":"Chen","year":"2019","journal-title":"Aging"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0105","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.talanta.2005.03.006","article-title":"Direct and two-stage data analysis procedures based on PCA, PLS-DA and ANN for ISE-based electronic tongue\u2014effect of supervised feature extraction","volume":"67","author":"Ciosek","year":"2005","journal-title":"Talanta"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0110","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0115","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.rbp.2012.07.004","article-title":"Bipolar disorder and metabolic syndrome: a systematic review","volume":"35","author":"Czepielewski","year":"2013","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0120","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.schres.2017.09.021","article-title":"A systematic review of metabolite biomarkers of schizophrenia","volume":"195","author":"Davison","year":"2018","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0125","series-title":"Metabolic Profiling","first-page":"149","article-title":"Rat fecal metabolomics-based analysis","author":"Deda","year":"2018"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0130","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.chroma.2018.05.007","article-title":"Method selectivity evaluation using the co-feature ratio in LC\/MS metabolomics: comparison of HILIC stationary phase performance for the analysis of plasma, urine and cell extracts","volume":"1568","author":"Elmsj\u00f6","year":"2018","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0135","series-title":"Metabonomics","first-page":"161","article-title":"The strengths and weaknesses of NMR spectroscopy and mass spectrometry with particular focus on metabolomics research","author":"Emwas","year":"2015"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0140","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1039\/c3np70086k","article-title":"Mass spectrometry in plant metabolomics strategies: from analytical platforms to data acquisition and processing","volume":"31","author":"Ernst","year":"2014","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0145","series-title":"Prostate Cancer","first-page":"237","article-title":"NMR-based prostate cancer metabolomics","author":"Euceda","year":"2018"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0150","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fphar.2016.00297","article-title":"From metabonomics to pharmacometabonomics: the role of metabolic profiling in personalized medicine","volume":"7","author":"Everett","year":"2016","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0155","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1177\/0004563213497929","article-title":"Pharmacometabonomics and personalized medicine","volume":"50","author":"Everett","year":"2013","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/0471142727.mb3004s114","article-title":"Metabolomics by gas chromatography\u2013mass spectrometry: combined targeted and untargeted profiling","volume":"114","author":"Fiehn","year":"2016","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0165","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1039\/C6MB00233A","article-title":"NMR analysis of the human saliva metabolome distinguishes dementia patients from matched controls","volume":"12","author":"Figueira","year":"2016","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.eurpsy.2017.12.001","article-title":"Platform for systems medicine research and diagnostic applications in psychotic disorders\u2014the METSY project","volume":"50","author":"Frank","year":"2018","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0175","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3164\/jcbn.12-118","article-title":"NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers","volume":"52","author":"Fukuhara","year":"2013","journal-title":"J. Clin. Biochem. Nutr."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0180","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1021\/acs.jproteome.7b00847","article-title":"Developing and standardizing a protocol for quantitative proton nuclear magnetic resonance (1H NMR) spectroscopy of saliva","volume":"17","author":"Gardner","year":"2018","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0185","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13229-016-0109-5","article-title":"Urinary metabolomics of young Italian autistic children supports abnormal tryptophan and purine metabolism","volume":"7","author":"Gevi","year":"2016","journal-title":"Mol. Autism"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0190","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.neuroimage.2016.03.075","article-title":"Using neuroimaging to help predict the onset of psychosis","volume":"145","author":"Gifford","year":"2017","journal-title":"Neuroimage"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0195","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.2147\/NDT.S164134","article-title":"Plasma disturbance of phospholipid metabolism in major depressive disorder by integration of proteomics and metabolomics","volume":"14","author":"Gui","year":"2018","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0200","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.bbi.2015.10.001","article-title":"Towards a blood-based diagnostic panel for bipolar disorder","volume":"52","author":"Haenisch","year":"2016","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0205","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s11306-014-0747-6","article-title":"Untargeted metabolomics studies employing NMR and LC\u2013MS reveal metabolic coupling between Nanoarcheum equitans and its archaeal host Ignicoccus hospitalis","volume":"11","author":"Hamerly","year":"2015","journal-title":"Metabolomics"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0210","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.76","article-title":"Schizophrenia shows a unique metabolomics signature in plasma","volume":"2","author":"He","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0030327","article-title":"Metabolic profiling of CSF: evidence that early intervention may impact on disease progression and outcome in schizophrenia","volume":"3","author":"Holmes","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0220","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research domain criteria (RDoC): toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196850","article-title":"The 1H-NMR-based metabolite profile of acute alcohol consumption: a metabolomics intervention study","volume":"13","author":"Irwin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0230","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.juro.2008.01.084","article-title":"Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography\/mass spectrometry","volume":"179","author":"Issaq","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0235","doi-asserted-by":"crossref","first-page":"9162","DOI":"10.1002\/anie.201410653","article-title":"Facing and overcoming sensitivity challenges in biomolecular NMR spectroscopy","volume":"54","author":"Jan-Henrik","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0240","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/0471250953.bi1413s53","article-title":"MetaboLights: an open-access database repository for metabolomics data","volume":"53","author":"Kale","year":"2016","journal-title":"Curr. Protoc. Bioinformatics"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0245","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1093\/nar\/gkr988","article-title":"KEGG for integration and interpretation of large-scale molecular data sets","volume":"40","author":"Kanehisa","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0250","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.anaerobe.2017.12.007","article-title":"Differences in fecal microbial metabolites and microbiota of children with autism spectrum disorders","volume":"49","author":"Kang","year":"2018","journal-title":"Anaerobe"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0255","doi-asserted-by":"crossref","first-page":"20150363","DOI":"10.1098\/rsta.2015.0363","article-title":"Towards quantitative mass spectrometry-based metabolomics in microbial and mammalian systems","volume":"374","author":"Kapoore","year":"2016","journal-title":"Phil. Trans. R. Soc. A"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0260","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/pcn.12638","article-title":"Plasma metabolome analysis of patients with major depressive disorder","volume":"72","author":"Kawamura","year":"2018","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0265","series-title":"Clinical Metabolomics","first-page":"317","article-title":"NMR analysis of fecal samples","author":"Kim","year":"2018"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0270","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2014.19","article-title":"A snapshot of plasma metabolites in first-episode schizophrenia: a capillary electrophoresis time-of-flight mass spectrometry study","volume":"4","author":"Koike","year":"2014","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0275","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.mp.4002130","article-title":"Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder","volume":"14","author":"Lan","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.pnpbp.2019.03.010_bb0280","doi-asserted-by":"crossref","first-page":"e13226","DOI":"10.1111\/petr.13226","article-title":"Non-invasive staging of chronic kidney allograft damage using urine metabolomic profiling","volume":"22","author":"Landsberg","year":"2018","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0285","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/2213235X113019990004","article-title":"NMR metabolomics analysis of Parkinson's Disease","volume":"1","author":"Lei","year":"2013","journal-title":"Curr. Metabol."},{"issue":"29","key":"10.1016\/j.pnpbp.2019.03.010_bb0290","doi-asserted-by":"crossref","first-page":"25435","DOI":"10.1074\/jbc.R111.238691","article-title":"Mass spectrometry strategies in metabolomics","volume":"286","author":"Lei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0295","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.brs.2018.02.003","article-title":"A precision medicine approach to repetitive Transcranial Magnetic Stimulation (rTMS)","volume":"11","author":"Leuchter","year":"2018","journal-title":"Brain Stimul."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0300","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ajmg.b.32662","article-title":"Metabolomics in patients with psychosis: a systematic review","volume":"177","author":"Li","year":"2018","journal-title":"Am. J. Med. Genet. B Neuropsychiatr. Genet."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0305","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11306-017-1199-6","article-title":"Discrimination of pancreatic cancer and pancreatitis by LC-MS metabolomics","volume":"13","author":"Lindahl","year":"2017","journal-title":"Metabolomics"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0310","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1039\/C4MB00157E","article-title":"GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells","volume":"10","author":"Liu","year":"2014","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0315","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13020-018-0211-z","article-title":"Blood and urinary metabolomic evidence validating traditional Chinese medicine diagnostic classification of major depressive disorder","volume":"13","author":"Liu","year":"2018","journal-title":"Chin. Med."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0320","series-title":"Biocomputing 2007","first-page":"157","article-title":"New bioinformatics resources for metabolomics","author":"Markley","year":"2007"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0325","doi-asserted-by":"crossref","first-page":"63","DOI":"10.31887\/DCNS.2014.16.1\/dmartins","article-title":"Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder","volume":"16","author":"Martins-de-Souza","year":"2014","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0330","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/bdi.12162","article-title":"Advancing biomarker research: utilizing \u201cBig Data\u201d approaches for the characterization and prevention of bipolar disorder","volume":"16","author":"McIntyre","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0335","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/mas.20205","article-title":"Capillary electrophoresis\u2013mass spectrometry as a powerful tool in biomarker discovery and clinical diagnosis: an update of recent developments","volume":"28","author":"Mischak","year":"2009","journal-title":"Mass Spectrom. Rev."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0340","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s00213-018-4992-7","article-title":"Plasma metabolomic profiling of a ketamine and placebo crossover trial of major depressive disorder and healthy control subjects","volume":"235","author":"Moaddel","year":"2018","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0345","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cca.2017.10.029","article-title":"Metabolomic analysis\u2014addressing NMR and LC-MS related problems in human feces sample preparation","volume":"489","author":"Moosmang","year":"2019","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0350","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1021\/acs.analchem.7b04089","article-title":"NMR-guided mass spectrometry for absolute quantitation of human blood metabolites","volume":"90","author":"Nagana Gowda","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0355","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u201cMetabonomics\u201d: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0360","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41398-018-0183-x","article-title":"Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study","volume":"8","author":"Pan","year":"2018","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0365","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1017\/S1461145714000157","article-title":"Metabolomic profiling of schizophrenia patients at risk for metabolic syndrome","volume":"17","author":"Paredes","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0370","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1021\/np200993k","article-title":"Quantitative 1H NMR. Development and potential of an analytical method: an update","volume":"75","author":"Pauli","year":"2012","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0375","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/sj.mp.4001511","article-title":"Mitochondrial dysfunction in schizophrenia: evidence for compromised brain metabolism and oxidative stress","volume":"9","author":"Prabakaran","year":"2004","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0380","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.1991.tb00673.x","article-title":"Molecular biology and pathology of scrapie and the prion diseases of humans","volume":"1","author":"Prusiner","year":"1991","journal-title":"Brain Pathol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016957","article-title":"The human serum metabolome","volume":"6","author":"Psychogios","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0390","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1039\/C7CC09891J","article-title":"Compression of multidimensional NMR spectra allows a faster and more accurate analysis of complex samples","volume":"54","author":"Puig-Castellv\u00ed","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0395","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.psychres.2017.08.039","article-title":"A preliminary study of bipolar disorder type I by mass spectrometry-based serum lipidomics","volume":"258","author":"Ribeiro","year":"2017","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0400","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.5740\/jaoacint.17-0093","article-title":"Certified reference material for use in 1H, 31P, and 19F quantitative NMR, ensuring traceability to the international system of units","volume":"100","author":"Rigger","year":"2017","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0405","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1021\/np050255w","article-title":"Metabolomics reviewed: a new \u201comics\u201d platform technology for systems biology and implications for natural products research","volume":"68","author":"Rochfort","year":"2005","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0410","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1160\/TH08-06-0348","article-title":"Omics meets hypothesis-driven research","volume":"100","author":"R\u00fcegg","year":"2008","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0415","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv096","article-title":"Omics-based biomarkers: application of metabolomics in neuropsychiatric disorders","volume":"19","author":"Sethi","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0420","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40345-017-0088-2","article-title":"1 H-NMR, 1 H-NMR T 2-edited, and 2D-NMR in bipolar disorder metabolic profiling","volume":"5","author":"Sethi","year":"2017","journal-title":"Int. J. Bipolar Disord."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0425","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165267","article-title":"Plasma metabolites predict severity of depression and suicidal ideation in psychiatric patients-a multicenter pilot analysis","volume":"11","author":"Setoyama","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0430","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.ftd.0000179845.53213.39","article-title":"METLIN: a metabolite mass spectral database","volume":"27","author":"Smith","year":"2005","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0435","series-title":"Methods and Protocols","first-page":"195","article-title":"Proton nuclear magnetic resonance (1H NMR) spectroscopy-based analysis of lipid components in serum\/plasma of patients with Duchenne muscular dystrophy (DMD) BT - Duchenne muscular dystrophy","author":"Srivastava","year":"2018"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0440","doi-asserted-by":"crossref","first-page":"D463","DOI":"10.1093\/nar\/gkv1042","article-title":"Metabolomics Workbench: an international repository for metabolomics data and metadata, metabolite standards, protocols, tutorials and training, and analysis tools","volume":"44","author":"Sud","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0445","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s11306-009-0178-y","article-title":"Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer-specific profiles","volume":"6","author":"Sugimoto","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0450","doi-asserted-by":"crossref","first-page":"96","DOI":"10.2174\/157489312799304431","article-title":"Bioinformatics tools for mass spectroscopy-based metabolomic data processing and analysis","volume":"7","author":"Sugimoto","year":"2012","journal-title":"Curr. Bioinforma."},{"issue":"23","key":"10.1016\/j.pnpbp.2019.03.010_bb9000","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1021\/ac901502j","article-title":"Metabolic profiling of human blood serum from treated patients with bipolar disorder employing 1H NMR spectroscopy and chemometrics","volume":"81","author":"Sussulini","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0455","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.222","article-title":"Serum metabolite profile associates with the development of metabolic co-morbidities in first-episode psychosis","volume":"6","author":"Suvitaival","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0460","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.schres.2016.12.024","article-title":"Metabolomics and lipidomics analyses by 1H nuclear magnetic resonance of schizophrenia patient serum reveal potential peripheral biomarkers for diagnosis","volume":"185","author":"Tasic","year":"2017","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0465","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3390\/ijms17071167","article-title":"Clinical metabolomics: the new metabolic window for inborn errors of metabolism investigations in the post-genomic era","volume":"17","author":"Tebani","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0470","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/pr060594q","article-title":"Chemometrics in metabolomics","volume":"6","author":"Trygg","year":"2007","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0475","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3389\/fbioe.2015.00087","article-title":"MetabNet: an R package for metabolic association analysis of high-resolution metabolomics data","volume":"3","author":"Uppal","year":"2015","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0480","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1186\/1471-2105-16-S18-S1","article-title":"An adaptive genetic algorithm for selection of blood-based biomarkers for prediction of Alzheimer's disease progression","volume":"16","author":"Vandewater","year":"2015","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0485","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1111\/bph.12494","article-title":"A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks","volume":"171","author":"Villase\u00f1or","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0490","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/phar.2119","article-title":"Atypical antipsychotic exposure may not differentiate metabolic phenotypes of patients with schizophrenia","volume":"38","author":"Ward","year":"2018","journal-title":"Pharmacother. J. Hum. Pharmacol. Drug Ther."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0495","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1021\/ac0713510","article-title":"Visualization of GC\/TOF-MS-based metabolomics data for identification of biochemically interesting compounds using OPLS class models","volume":"80","author":"Wiklund","year":"2008","journal-title":"Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0500","doi-asserted-by":"crossref","first-page":"D608","DOI":"10.1093\/nar\/gkx1089","article-title":"HMDB 4.0: the human metabolome database for 2018","volume":"46","author":"Wishart","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0505","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/npp.2013.167","article-title":"Mass spectrometry strategies for clinical metabolomics and lipidomics in psychiatry, neurology, and neuro-oncology","volume":"39","author":"Wood","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0510","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0\u2014making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trac.2011.08.009","article-title":"Metabolite identification and quantitation in LC-MS\/MS-based metabolomics","volume":"32","author":"Xiao","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0520","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1039\/c3mb70614a","article-title":"2,4-Dihydroxypyrimidine is a potential urinary metabolite biomarker for diagnosing bipolar disorder","volume":"10","author":"Xu","year":"2014","journal-title":"Mol. BioSyst."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0525","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/mp.2011.131","article-title":"Potential metabolite markers of schizophrenia","volume":"18","author":"Yang","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0530","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bbacli.2016.03.008","article-title":"Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder","volume":"5","author":"Yoshimi","year":"2016","journal-title":"BBA Clin."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0535","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jad.2016.02.008","article-title":"Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells","volume":"195","author":"Zheng","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.pnpbp.2019.03.010_bb0540","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.cca.2016.11.039","article-title":"Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine","volume":"464","author":"Zheng","year":"2017","journal-title":"Clin. Chim. Acta"}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618309011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584618309011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T19:48:23Z","timestamp":1759520903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584618309011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":110,"alternative-id":["S0278584618309011"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.03.010","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advances and challenges in development of precision psychiatry through clinical metabolomics on mood and psychotic disorders","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}